VALENCIA, Calif. & MELBOURNE, Australia--(<span itemprop="provider publisher copyrightHolder" itemscope="itemscope" itemtype="https://schema.org/Organization" itemid="https://www.businesswire.com"><span itemprop="name"><a referrerpolicy="unsafe-url" rel="nofollow" itemprop="url" href="https://www.businesswire.com/">BUSINESS WIRE</a></span></span>--AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine
company, today announced that key opinion leaders from five U.S. burn
centers presented clinical results of the RECELL® Autologous Cell
Harvesting Device (RECELL® System) at two U.S. burn conferences, the
31st Annual Southern Region Burn CME Conference held in Mobile, AL and
the Northeast Region Burn Conference held in Cambridge, MA. In addition,
the burn surgeons led two medical education symposiums on the use of the
RECELL System at the conferences.
Great Puzzle, page-13
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
-0.020(0.81%) |
Mkt cap ! $166.8M | |||
| Open | High | Low | Value | Volume |
| $2.47 | $2.49 | $2.44 | $130.6K | 52.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 33235 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 20078 | 5 |
View Market Depth
| Last trade - 11.26am 11/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |